Clinical Trials Logo

Rhinitis clinical trials

View clinical trials related to Rhinitis.

Filter by:

NCT ID: NCT04648930 Completed - Allergic Rhinitis Clinical Trials

Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

Start date: January 27, 2021
Phase:
Study type: Observational

This was a multicenter, uncontrolled, open-label, special drug use study to investigate the safety and efficacy of Xolair by collecting data in its clinical setting in patients with severe to most severe seasonal allergic rhinitis aged ≥ 12 years and < 18 years whose symptoms were inadequately controlled despite to conventional therapies and used Xolair.

NCT ID: NCT04645979 Completed - Rhinitis, Allergic Clinical Trials

A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

Start date: November 11, 2020
Phase:
Study type: Observational

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever. In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

NCT ID: NCT04637425 Completed - Allergic Rhinitis Clinical Trials

Effect of Bacterial Lysate on Nasal Carriage of Staphylococcus Aureus

Start date: April 22, 2018
Phase: Phase 3
Study type: Interventional

This study assesses the effectiveness of Polyvalent Mechanical Bacterial Lysate (PMBL-Ismigen) in reducing nasal methicillin-resistant Staphylococcus aureus (MRSA) colony growth in children with pollen allergic rhinitis (AR) aged 5 to 17. Half of the participants received PMBL and the other half received a placebo.

NCT ID: NCT04622917 Completed - Allergic Rhinitis Clinical Trials

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

Start date: April 10, 2019
Phase: Phase 4
Study type: Interventional

This study evaluates the effect of intramuscular injected methylprednisolone treating birch pollen induced rhinitis compared to placebo.

NCT ID: NCT04621513 Recruiting - Clinical trials for Pediatric Sleep Apnea

Collaborative Care Model for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.

Start date: July 29, 2020
Phase: N/A
Study type: Interventional

In this project,the investigators aim to establish a Collaborative Care Model of TCM and Western Medicine to improve the quality of life and symptoms of AR with OSA children and educate care-givers diet and massage information to improve self-care ability and alleviate anxiety for parents. In addition, the investigators will use portable oxymeter to detect the change of SpO2 and respiratory arousal index daily at home and evaluate sensitivity and specificity of portable oxymeter device applied in OSA. The investigators want to give holistic health care for participants and care-givers by this project. In addition, the investigators will build a training environment to provide medical education and training opportunity to teach medical students and clinician the knowledge of pediatric allergic rhinitis and obstructive sleep apnea by caring patients and learning from clinical cases.

NCT ID: NCT04619017 Active, not recruiting - Allergic Rhinitis Clinical Trials

Airway Immune Response to Allergens (Use Lay Language Here)

Start date: October 28, 2021
Phase: Phase 1
Study type: Interventional

Most asthma is allergic in origin. The purpose of this study is to better understand the airway immune response to inhaled allergens in order to identify factors that promote asthma.

NCT ID: NCT04614324 Active, not recruiting - Chronic Rhinitis Clinical Trials

A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)

RELIEF
Start date: October 5, 2020
Phase: N/A
Study type: Interventional

Post-market study to continue to evaluate the effectiveness of the RhinAer ARC Stylus for chronic rhinitis.

NCT ID: NCT04603456 Completed - Allergic Rhinitis Clinical Trials

miRNA-155 Assay Before and After Immunotherapy and Probiotics

Start date: September 1, 2018
Phase: Phase 4
Study type: Interventional

The investigators aimed to explore miRNA-155 change in response to sublingual immunotherapy (SLIT), probiotics and combined treatment with SLIT and probiotics in AR children.

NCT ID: NCT04601324 Withdrawn - Allergic Rhinitis Clinical Trials

Allergic Rhinitis Combination Pharmacotherapy Efficacy Study

Start date: December 15, 2020
Phase: Phase 4
Study type: Interventional

Combination pharmacotherapy is often used in people who have failed mono-therapies in managing their bothersome allergic rhinitis symptoms . However, there is a paucity of research indicating the most effective combination therapies in managing allergic rhinitis. This study aims to evaluate the efficacy of oral antihistamine (rupatadine) combined with nasal steroid (fluticasone propionate) compared to a well-studied combination therapy of nasal steroid with nasal antihistamine spray (MP-AzeFlu).

NCT ID: NCT04583202 Completed - Allergic Rhinitis Clinical Trials

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Start date: February 24, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to assess the nasal and conjunctival response in subjects allergic to birch pollen during controlled exposures in the ALYATEC environmental exposure chamber (EEC)